Levoleucovorin — Drug Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

7 Recruiting

3 Completed trials

9 Sponsors

3 Countries

Phase III

Phase II

Phase III: 3 Phase II/III: 1 Phase II: 8

Indications tested

Adenocarcinoma gastric 1 Rectal cancer 1 Neoadjuvant therapy 1 Colon cancer 1

Sponsors using this IMP

Association Gercor 2 Centre Hospitalier Universitaire Rouen 2 Groupe Belge D'Oncologie Digestive 2 Centre Hospitalier Universitaire De Bordeaux 1 Fondation Franc.Cancerologie Digestive 1 Fondazione IRCCS Istituto Nazionale Dei Tumori 1 Institut De Cancerologie De L Ouest 1 Institut Regional Du Cancer De Montpellier 1 Unicancer 1

All trials

12 total

Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Duct… Pending

2024-518139-12-00 Phase II 1 country Association Gercor
BALLAD Belgium - A trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma. The Belgian component of… Pending

2024-518349-85-01 Phase III 1 country Groupe Belge D'Oncologie Digestive
Pancreatic cancer first-line NALIRIFOX optimization with 5-FU maintenance and role of antibiotics and microbiota exploration in second-line … Recruiting

2024-517766-41-00 Phase II 1 country Association Gercor
Risk-adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with… Recruiting

2024-519048-33-00 Phase II/III 1 country Centre Hospitalier Universitaire Rouen
Neoadjuvant Chemotherapy for Obstructive Colon cancER first Treated by cOlostomy : A randomized phase III trial - COnCERTO (French 01-18) 20… Recruiting

2024-516456-17-00 Phase III 1 country Centre Hospitalier Universitaire Rouen
Oxaliplatin ± nivolumab in combination with trifluridine/tipiracil or 5- fluorouracile ± nivolumab in frail patients with advanced, recurren… Recruiting

2024-512999-35-00 Phase II 1 country Unicancer
“NALPAC” A NON-COMPARATIVE RANDOMIZED PHASE 2 STUDY, EVALUATING THE EFFICACY OF 5-FU + NALIRI AND 5-FU + NALIRINOX FOR METASTATIC PANCREATIC… Recruiting

2024-516336-97-00 Phase II 1 country Groupe Belge D'Oncologie Digestive
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cance… Recruiting

2024-515344-23-00 Phase II 1 country Institut Regional Du Cancer De Montpellier
Phase II study of adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) for the prevention of peritoneal metastases after curati… Recruiting

2024-513376-17-00 Phase II 1 country Fondazione IRCCS Istituto Nazionale Dei Tumori
A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as pre-operative treatment f… Ended

2024-514705-62-00 Phase III 1 country Centre Hospitalier Universitaire De Bordeaux
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient… Ended

2024-518741-21-00 Phase II 2 countries Fondation Franc.Cancerologie Digestive
Open-label non-randomized multicentric phase 2 study evaluating the combination of bemarituzumab + FLOT chemotherapy in perioperative settin… Ended

2024-514078-29-00 Phase II 1 country Institut De Cancerologie De L Ouest

Showing 1–12 of 12 trials

← All drugs A–Z